Potent in vitro and xenograft antitumor activity of a novel agent, PV-10, against relapsed and refractory neuroblastoma

PURPOSE: Neuroblastoma is the most common extracranial cancer in children. Although the prognosis for low-risk neuroblastoma patients is good, the 5-year survival rates for high-risk and relapsed patients are low. The poor survival rates for these patients demonstrate the need for novel therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Swift, Lucy, Zhang, Chunfen, Trippett, Tanya, Narendran, Aru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388978/
https://www.ncbi.nlm.nih.gov/pubmed/30863096
http://dx.doi.org/10.2147/OTT.S191478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388978/
https://www.ncbi.nlm.nih.gov/pubmed/30863096
http://dx.doi.org/10.2147/OTT.S191478

Ejemplares similares